Fortrea
Stephania Byrne is a Clinical Research Associate II at Fortrea since August 2022, previously holding the position of Clinical Research Associate I. Prior experience includes roles as an In-House Clinical Research Associate and Study Start Up Associate at Labcorp Drug Development, where responsibilities involved managing site compliance and ensuring readiness for trials. At Sarah Cannon Research Institute, the role of Protocol Interpreter involved reviewing financial impacts of trial amendments. Earlier, Stephania worked at ICON plc as a Study Start Up Associate and Clinical Trial Assistant, supporting clinical teams through regulatory compliance and document management. An English Teacher at Hanyang University and a Student Ambassador at Vanderbilt University, Stephania holds a Bachelor of Arts in Neuroscience from Vanderbilt University and a Graduate Certificate in Pharmaceutical Management from Cornell University.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.